Palisade (pathology)

Last updated
Micrograph of an ameloblastoma showing characteristic palisading. H&E stain. Ameloblastoma - high mag.jpg
Micrograph of an ameloblastoma showing characteristic palisading. H&E stain.

In histopathology, a palisade is a single layer of relatively long cells, arranged loosely perpendicular to a surface and parallel to each other. [1] A rosette is a palisade in a halo or spoke-and-wheel arrangement, surrounding a central core or hub. [2] A pseudorosette is a perivascular radial arrangement of neoplastic cells around a small blood vessel. [2]

Contents

Rosette

Structure of a rosette in pathology. Structure of a rosette in pathology.jpg
Structure of a rosette in pathology.
Rosettes are named after the flower-like architectural ornament. Orna115-Rosetten.png
Rosettes are named after the flower-like architectural ornament.

A rosette is a cell formation in a halo or spoke-and-wheel arrangement, surrounding a central core or hub. The central hub may consist of an empty-appearing lumen or a space filled with cytoplasmic processes. The cytoplasm of each of the cells in the rosette is often wedge-shaped with the apex directed toward the central core: the nuclei of the cells participating in the rosette are peripherally positioned and form a ring or halo around the hub. [2]

Pathogenesis

Rosettes may be considered primary or secondary manifestations of tumor architecture. Primary rosettes form as a characteristic growth pattern of a given tumor type whereas secondary rosettes result from the influence of external factors on tumor growth. For example, in the latter instance, regressive cell swelling may centripetally displace the cytoplasm as the nucleus is squeezed to the periphery. Although the presence of primary rosettes may suggest a given diagnosis, usually this finding alone is not considered absolutely pathognomic for one specific tumor type. [2]

Loss or gain of genetic information is the main cause of rosette and pseudorosette formation. The cell populations exhibiting neuronal differentiation are believed to secrete surface glycoproteins and glycolipids which mediate cell-to-cell recognition and adhesion. One hypothesis is that these sticky cell surface markers cause the developing cell bodies to cluster or aggregate and their primitive neurites to tangle. As the cells grow, the neurite tangle remains centrally located and the cell bodies are squeezed to the periphery, thus explaining the rosette pattern. Depending upon their location, ependymal cells may display 2 cell poles. A luminal pole projects to the ependymal lining of a ventricle and a “submesenchymal pole” projects toward the surface of the brain demonstrating glial processes and peripherally situated footplates. Frieda and Pollak conceptualize the architecture of ependymomas as a primitive neural tube turned inside out with the submesenchymal poles converging toward a central vessel, thus forming a pseudorosette rather than projecting centrifugally toward the pia. [2]

Causes

True rosettes are mainly found in neuropathologic disorder and are also present in osteosarcoma, non-Hodgkin lymphoma, fibromyxoid sarcoma, medullary thyroid carcinoma, embryonal tumor with abundant neuropil and true rosettes (ETANTR), rhambdomyosarcoma, chronic cholestasis and chronic active hepatitis, tobacco rosette: complex viral disease, malaria, adenocarcinoma in colon and rectum in the Aghamiri population, hyalinizing spindle cell fused with giant rosette, endometrial stromal sarcoma with hyalinizing giant rosettes, embryonal tumor etc. [2]

Flexner–Wintersteiner rosettes (spoke-and-wheel shaped cell formation seen mainly in retinoblastoma [3] ) have been described as a form of palisading. [4]

Flexner–Wintersteiner rosette

Flexner-Wintersteiner rosettes in Retinoblastoma. Retinoblastoma rosette.jpg
Flexner–Wintersteiner rosettes in Retinoblastoma.

A Flexner–Wintersteiner rosette is a spoke-and-wheel shaped cell formation seen in retinoblastoma and certain other ophthalmic tumors. [3]

Unlike the center of the Homer Wright rosette, the central lumen is devoid of fiber-rich neuropil. The defining feature of this rosette is central extension of cytoplasmic projections of the surrounding cells. Like the Homer Wright rosette, the Flexner–Wintersteiner rosette represents a specific form of tumor differentiation. [5] [6] [7] [8] Electron microscopy reveals that the tumor cells forming the Flexner–Wintersteiner rosette have ultrastructural features of primitive photoreceptor cells. [9] Furthermore, the rosette lumen shows similar staining patterns as in rods and cones, [10] suggesting that Flexner–Wintersteiner rosettes represent a specific form of retinal differentiation. In addition to being a characteristic finding in retinoblastomas, Flexner–Wintersteiner rosettes may also be found in pinealoblastomas and medulloepitheliomas. [5]

Flexner–Wintersteiner rosettes were first described by Simon Flexner (1863–1946), a physician, scientist, administrator, and professor of experimental pathology at the University of Pennsylvania (1899–1903). Flexner noted characteristic clusters of cells in an infantile eye tumor which he called retinoepithelioma. [11] [12] [13] A few years later, in 1897, Austrian ophthalmologist Hugo Wintersteiner (1865–1946) confirmed Flexner's observations and noted that the cell clusters resembled rods and cones. [14] These characteristic rosette formations were subsequently recognized as important features of retinoblastomas.

Pseudorosette

A pseudorosette is a perivascular radial arrangement of neoplastic cells around a small blood vessel. Pseudorosettes are present in neuroblastoma, medulloblastoma, malignant melanoma, ependymoma, Merkel cell carcinoma, neuroendocrine tumor of skin, seborrheic keratosis, dendritic cell neurofibroma, astroblastoma, large cell neuroendocrine tumor of cervix, clear cell ependymoma of spinal cord, celiac disease, nasal tumor of olfactory origin, rosette forming glioneural tumor (RGNT), oncocytoma, Wilm's tumor, pheochromocytoma of urinary bladder. [2]

Homer Wright pseudorosette

Micrograph of Homer Wright pseudorosettes Micrograph of Homer Wright pseudorosettes.jpg
Micrograph of Homer Wright pseudorosettes

A Homer Wright pseudorosette is a type of pseudorosette in which differentiated tumor cells surround the neuropil. [15] Examples of tumors containing these are neuroblastoma, medulloblastoma, pinealoblastoma, and primitive neuroectodermal tumors of bone. Homer Wright rosettes are considered "pseudo" in the sense that they are not true rosettes. True rosettes are Flexner–Wintersteiner rosette, which contain an empty lumen. Homer Wright rosettes contain abundant fibrillary material. They are named for James Homer Wright.

Perivascular pseudorosette

A perivascular pseudorosette consists of a spoke-wheel arrangement of cells with tapered cellular processes radiates around a wall of a centrally placed vessel. The modifier “pseudo” differentiates this pattern from the Homer Wright and Flexner-Wintersteiner rosettes, perhaps because the central structure is not actually formed by the tumor itself, but instead represents a native, non-neoplastic element. Also, some early investigators argued about the definition of a central lumen, choosing “pseudo” to indicate that the hub was not a true lumen but contained structures. Nevertheless, this pattern remains extremely diagnostically useful and the modifier unnecessarily leads to confusion. Perivascular pseudorosettes are encountered in most ependymomas regardless of grade or variant. As such, they are significantly more sensitive for the diagnosis of ependymomas than true ependymal rosettes. Unfortunately, perivascular pseudorosettes are also less specific in that they are also encountered in medulloblastomas, PNETs, central neurocytomas, and less often in glioblastomas, and a rare pediatric tumor, monomorphous pilomyxoid astrocytomas. [2]

Pineocytomatous/neurocytic pseudorosettes

Histologic features of these two tumors are virtually identical, including their tendency to form neuropilrich rosettes, referred to as pineocytomatous/neurocytic rosettes in central neurocytoma. Both are quite similar to the Homer Wright rosette, but they are generally larger and more irregular in contour. The cells of the pineocytomatous/neurocytic rosettes are also considered to be much more differentiated than the cells forming Homer Wright rosettes in that the nuclei are slightly larger, more rounded, much less mitotically active, and paler or less hyperchromatic. In rare cases, these rosettes may aggregate in a sheet of back-to-back clusters resembling field stone pavement. [2]

Clinical significance of rosettes and pseudorosettes

The neuropathologic diagnosis of brain tumors entails the microscopic examination of conventional formalin-fixed paraffin-embedded tissue samples surgically removed from a radiographically defined lesion. Pathologists rely on visual clues such as pattern recognition when examining the stained tissue with a microscope, much as radiologists rely on grayscale patterns of densities and intensities on images. Some histologic patterns of cellular architecture are distinctive if not pathognomonic whereas others are less specific, but nevertheless considerably narrow the differential diagnosis. The precise biologic bases for some of the observed microscopic patterns are poorly understood though their recognition remains useful nonetheless. One commonly encountered neuropathologic histologic architectural pattern seen within certain tumors is the rosette. The purpose of this report is to review the patterns of rosettes and pseudorosettes in the context of such tumors as medulloblastoma/primitive neuroectodermal tumor (PNET), retinoblastoma, ependymoma, central neurocytoma and pineocytoma. [2]

Methods for diagnosis of rosettes and pseudorosettes

More advanced methods of tissue examination such as histochemical and immunohistochemical profiling, genetic analysis, and electron microscopy have been developed, the microscopic review of H&E stained material remains a critical component of tumor diagnosis. Immunohistochemical evidence of neuronal differentiation is found in nearly all cases with neuronal markers such as synaptophysin, neuronspecific enolase, and neurofilament protein. Some medulloblastomas may also display other forms of differentiation as demonstrated by the presence of the astrocytic marker glial fibrillary acidic protein. Skeletal muscle and melanocytic differentiation are considerably less common and define the medullomyoblastoma and melanotic medulloblastoma variants, respectively. [2]

Long palisades

Palisading in nodular basal-cell carcinoma. Palisading in basal cell cancer.jpg
Palisading in nodular basal-cell carcinoma.

Palisades that are generally longer than a rosette or pseudorosette can be seen in neural tumors such as Schwannoma, [16] [17] as well as in ameloblastomas. It can also be seen in nodular basal-cell carcinomas. [18]

Visually similar findings

Pseudopalisading, a visually similar finding, is the formation of hypercellular zones that typically surrounds necrotic tissue.

Related Research Articles

<span class="mw-page-title-main">Ependymoma</span> Medical condition

An ependymoma is a tumor that arises from the ependyma, a tissue of the central nervous system. Usually, in pediatric cases the location is intracranial, while in adults it is spinal. The common location of intracranial ependymomas is the fourth ventricle. Rarely, ependymomas can occur in the pelvic cavity.

<span class="mw-page-title-main">Embryonal carcinoma</span> Relatively uncommon type of germ cell tumour

Embryonal carcinoma is a relatively uncommon type of germ cell tumour that occurs in the ovaries and testes.

A blastoma is a type of cancer, more common in children, that is caused by malignancies in precursor cells, often called blasts. Examples are nephroblastoma, medulloblastoma, and retinoblastoma. The suffix -blastoma is used to imply a tumor of primitive, incompletely differentiated cells, e.g., chondroblastoma is composed of cells resembling the precursor of chondrocytes.

<span class="mw-page-title-main">Gleason grading system</span> Score given to a prostate cancer based on its microscopic appearance

The Gleason grading system is used to help evaluate the prognosis of men with prostate cancer using samples from a prostate biopsy. Together with other parameters, it is incorporated into a strategy of prostate cancer staging which predicts prognosis and helps guide therapy. A Gleason score is given to prostate cancer based upon its microscopic appearance. Cancers with a higher Gleason score are more aggressive and have a worse prognosis. Pathological scores range from 2 to 10, with higher numbers indicating greater risks and higher mortality. The system is widely accepted and used for clinical decision making even as it is recognised that certain biomarkers, like ACP1 expression, might yield higher predictive value for future disease course.

<span class="mw-page-title-main">Medulloblastoma</span> Most common type of primary brain cancer in children

Medulloblastoma is a common type of primary brain cancer in children. It originates in the part of the brain that is towards the back and the bottom, on the floor of the skull, in the cerebellum, or posterior fossa.

<span class="mw-page-title-main">Ganglioglioma</span> Medical condition

Ganglioglioma is a rare, slow-growing primary central nervous system (CNS) tumor which most frequently occurs in the temporal lobes of children and young adults

<span class="mw-page-title-main">Primitive neuroectodermal tumor</span> Medical condition

Primitive neuroectodermal tumor is a malignant (cancerous) neural crest tumor. It is a rare tumor, usually occurring in children and young adults under 25 years of age. The overall 5 year survival rate is about 53%.

Juxtaglomerular cell tumor is an extremely rare kidney tumour of the juxtaglomerular cells, with less than 100 cases reported in literature. This tumor typically secretes renin, hence the former name of reninoma. It often causes severe hypertension that is difficult to control, in adults and children, although among causes of secondary hypertension it is rare. It develops most commonly in young adults, but can be diagnosed much later in life. It is generally considered benign, but its malignant potential is uncertain.

<span class="mw-page-title-main">Pineoblastoma</span> Medical condition

Pineoblastoma is a malignant tumor of the pineal gland. A pineoblastoma is a supratentorial midline primitive neuroectodermal tumor. Pineoblastoma can present at any age, but is most common in young children. They account for 0.001% of all primary CNS neoplasms.

<span class="mw-page-title-main">WHO classification of tumours of the central nervous system</span>

The following is a simplified (deprecated) version of the 2021 WHO classification of the tumours of the central nervous system. Currently, as of 2021, clinicians are using the WHO grade 5th edition, which incorporates recent advances in molecular pathology.

<span class="mw-page-title-main">Subependymoma</span> Relatively benign brain cancer involving ependymal cells

A subependymoma is a type of brain tumor; specifically, it is a rare form of ependymal tumor. They are usually in middle aged people. Earlier, they were called subependymal astrocytomas.

<span class="mw-page-title-main">Medulloepithelioma</span> Medical condition

Medulloepithelioma is a rare, primitive, fast-growing brain tumour thought to stem from cells of the embryonic medullary cavity. Tumours originating in the ciliary body of the eye are referred to as embryonal medulloepitheliomas, or diktyomas.

Flexner is a surname. Notable people with the surname include:

Mucinous cystadenocarcinoma of the lung (MCACL) is a very rare malignant mucus-producing neoplasm arising from the uncontrolled growth of transformed epithelial cells originating in lung tissue.

Pediatric ependymomas are similar in nature to the adult form of ependymoma in that they are thought to arise from radial glial cells lining the ventricular system. However, they differ from adult ependymomas in which genes and chromosomes are most often affected, the region of the brain they are most frequently found in, and the prognosis of the patients. Children with certain hereditary diseases, such as neurofibromatosis type II (NF2), have been found to be more frequently afflicted with this class of tumors, but a firm genetic link remains to be established. Symptoms associated with the development of pediatric ependymomas are varied, much like symptoms for a number of other pediatric brain tumors including vomiting, headache, irritability, lethargy, and changes in gait. Although younger children and children with invasive tumor types generally experience less favorable outcomes, total removal of the tumors is the most conspicuous prognostic factor for both survival and relapse.

<span class="mw-page-title-main">Papillary tumors of the pineal region</span>

Papillary tumors of the pineal region (PTPR) were first described by A. Jouvet et al. in 2003 and were introduced in the World Health Organization (WHO) classification of Central Nervous System (CNS) in 2007. Papillary Tumors of the Pineal Region are located on the pineal gland which is located in the center of the brain. The pineal gland is located on roof of the diencephalon. It is a cone shaped structure dorsal to the midbrain tectum. The tumor appears to be derived from the specialized ependymal cells of the subcommissural organ. Papillary tumors of the central nervous system and particularly of the pineal region are very rare and so diagnosing them is extremely difficult.

<span class="mw-page-title-main">Central neurocytoma</span> Medical condition

Central neurocytoma (CNC) is an extremely rare, ordinarily benign intraventricular brain tumour that typically forms from the neuronal cells of the septum pellucidum. The majority of central neurocytomas grow inwards into the ventricular system forming interventricular neurocytomas. This leads to two primary symptoms of CNCs, blurred vision and increased intracranial pressure. Treatment for a central neurocytoma typically involves surgical removal, with an approximate 1 in 5 chance of recurrence. Central neurocytomas are classified as a grade II tumor under the World Health Organization's classification of tumors of the nervous system.

<span class="mw-page-title-main">Central nervous system primitive neuroectodermal tumor</span> Medical condition

A central nervous system primitive neuroectodermal tumor, often abbreviated as PNET, supratentorial PNET, or CNS-PNET, is one of the 3 types of embryonal central nervous system tumors. It is considered an embryonal tumor because it arises from cells partially differentiated or still undifferentiated from birth. Those cells are usually neuroepithelial cells, stem cells destined to turn into glia or neurons. It can occur anywhere within the spinal cord and cerebrum and can have multiple sites of origins, with a high probability of metastasis through cerebrospinal fluid (CSF).

Embryonal tumor with multilayered rosettes (ETMR) is an embryonal central nervous system tumor. It is considered an embryonal tumor because it arises from cells partially differentiated or still undifferentiated from birth, usually neuroepithelial cells, stem cells destined to turn into glia or neurons. It can occur anywhere within the brain and can have multiple sites of origins, with a high probability of metastasis through cerebrospinal fluid (CSF). Metastases outside the central nervous system have been reported, but remain rare.

References

  1. "palisading". The Free Dictionary by Farlex, citing Segen's Medical Dictionary, copyrighted 2012. Retrieved 2019-09-11.
  2. 1 2 3 4 5 6 7 8 9 10 11 12 Largely copied from: Ahmed, Mahtab Uddin (2017). "Rosettes and Pseudorosettes and Their Significance". Journal of Enam Medical College. 7 (2): 101–106. doi: 10.3329/jemc.v7i2.32656 . ISSN   2304-9316. Attribution 4.0 International (CC BY 4.0)
  3. 1 2 Definition of 'rosette', from The Free Dictionary. Retrieved 6 January 2010.
  4. page 666 in: Ben Z. Pilch (2001). Head and Neck Surgical Pathology. Lippincott Williams & Wilkins. ISBN   9780397517275.
  5. 1 2 McLean IW, Burnier MN, Zimmerman LE, et al. Tumors of the retina. In: Atlas of tumor pathology: tumors of the eye and ocular adnexa. Washington, DC: Armed Forces Institute of Pathology; 1994:97–154
  6. Donoso LA, Shields CL, Lee EY-H. Immunohistochemistry of retinoblastoma. Ophthal Paediatr Genet 1989;10:3–32
  7. Vrabec T, Arbizo V, Adamus G, et al. Rod cell-specific antigens in retinoblastoma. Arch Ophthalmol 1989;107:1061–63
  8. Kivela T. Glycoconjugates in retinoblastoma: a lectin histochemical study of ten formalin-fixed and paraffin embedded tumours. Virchows Arch A 1987;410:471–79
  9. Ts’o MOM, Fine BS, Zimmerman LE. The Flexner–Wintersteiner rosettes in retinoblastoma. Arch Pathol 1969;88:664–71
  10. Zimmerman LE. Retinoblastoma and retinocytoma. In: Spencer WH, ed. Ophthalmic pathology: an atlas and textbook. Philadelphia: WB Saunders; 1985:1292–351
  11. Flexner S. A peculiar glioma (neuroepithelioma?) of the retina. Johns Hopkins Hosp Bull 1891;2:115–19
  12. Schatski SC. Simon Flexner. AJR Am J Roentgenol 1997;169:1395–96.
  13. Bendiner E. Simon Flexner: his "rock" was for the ages. Hosp Pract 1988;23:213–66
  14. Wintersteiner H. Die zellen der geschwulst. In: Das neuroepithelioma retinae: Eine anatomische und klinishe studie. Leipzig: Franz Deuticke; 1897:12–16
  15. Wippold II, Franz J.; Perry, A. (March 2006). "Neuropathology for the Neuroradiologist: Rosettes and Pseudorosettes". American Journal of Neuroradiology. 27 (3): 488–492. PMC   7976948 . PMID   16551982 . Retrieved 26 August 2015.
  16. Wippold FJ, Lämmle M, Anatelli F, Lennerz J, Perry A (2006). "Neuropathology for the neuroradiologist: palisades and pseudopalisades". AJNR Am J Neuroradiol. 27 (10): 2037–41. PMC   7977220 . PMID   17110662.
  17. Kadono T, Okada H, Okuno T, Ohara K (June 1998). "Basal cell carcinoma with neuroid type nuclear palisading: a report of three cases". Br. J. Dermatol. 138 (6): 1064–6. doi:10.1046/j.1365-2133.1998.02281.x. PMID   9747376. S2CID   20339424.
  18. Initially copied from: Paolino, Giovanni; Donati, Michele; Didona, Dario; Mercuri, Santo; Cantisani, Carmen (2017). "Histology of Non-Melanoma Skin Cancers: An Update". Biomedicines. 5 (4): 71. doi: 10.3390/biomedicines5040071 . ISSN   2227-9059. PMC   5744095 . PMID   29261131.